Home / South Asia / LKA

Sri Lanka

Sri Lanka's National STD/AIDS Control Programme (NSACP), the national programme for HIV and other sexually transmitted diseases (STD), publishes an annual report with the HIV cases reported in every year. Our project reads the national count for 2010 to 2025 from Figure 2.6 of the 2025 annual report, and checks the count against 16 quarterly returns of the programme, which never enter the panel.

8,700

People living with HIV, 2025

WHO Global Health Observatory

52.0%

On antiretroviral treatment, 2025

WHO Global Health Observatory

$11k

United States HIV disbursements, 2020

ForeignAssistance.gov

$1.6m

External HIV financing, all donors, 2024

OECD Creditor Reporting System

External HIV financing

OECD CRS · ForeignAssistance.gov

All donors
United States, OECD record
The Global Fund
United States, self-reported

Year	All donors	United States, OECD record	The Global Fund	United States, self-reported
2002	$575k	—	—	—
2003	$458k	—	—	—
2004	$104k	—	—	—
2005	$840k	$173k	—	$56k
2006	$647k	$68k	—	$160k
2007	$1.8m	$52k	$303k	$79k
2008	$877k	$92k	—	$92k
2009	$562k	—	—	—
2010	$1.2m	$30k	$356k	$30k
2011	$4.1m	—	$3.4m	—
2012	$2.3m	—	$1.5m	—
2013	$4.6m	—	$4.4m	$45k
2014	$1.2m	—	$1.1m	$-1k
2015	$294k	—	—	$7k
2016	$2.2m	—	$2.1m	—
2017	$2.5m	—	$2.5m	—
2018	$4.2m	—	$4.1m	—
2019	$2.9m	—	$2.0m	—
2020	$7.3m	—	$2.2m	$11k
2021	$1.9m	—	$1.7m	—
2022	$2.8m	—	$2.7m	—
2023	$718k	—	$692k	—
2024	$1.6m	—	$1.5m	—

23 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment

UNAIDS AIDSinfo

People living with HIV
People on treatment

Year	People living with HIV	People living with HIV (lower)	People living with HIV (upper)	People on treatment
2000	2,500	2,200	2,900	—
2001	2,900	2,500	3,300	—
2002	3,200	2,700	3,700	—
2003	3,500	3,000	4,000	—
2004	3,700	3,200	4,200	—
2005	3,900	3,400	4,400	—
2006	4,000	3,500	4,600	—
2007	4,100	3,500	4,700	—
2008	4,100	3,600	4,700	—
2009	4,100	3,500	4,600	—
2010	4,000	3,500	4,600	500
2011	3,900	3,500	4,500	500
2012	3,900	3,500	4,400	500
2013	3,900	3,400	4,400	520
2014	3,900	3,500	4,400	640
2015	3,900	3,500	4,500	800
2016	4,000	3,600	4,600	1,100
2017	4,100	3,700	4,700	1,300
2018	4,300	3,800	4,800	1,600
2019	4,500	4,000	5,000	1,800
2020	4,700	4,200	5,200	2,200
2021	4,900	4,300	5,500	2,400
2022	5,100	4,500	5,800	2,800
2023	5,400	4,700	6,100	3,400
2024	5,700	4,900	6,500	4,100

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade

UNAIDS AIDSinfo

Diagnosed
On treatment
Virally suppressed

Year	Diagnosed	On treatment	Virally suppressed
2010	—	7.0%	—
2011	—	8.0%	—
2012	—	10.0%	—
2013	—	13.0%	—
2014	—	16.0%	—
2015	—	20.0%	—
2016	—	26.0%	21.0%
2017	38.0%	31.0%	26.0%
2018	45.0%	37.0%	31.0%
2019	52.0%	41.0%	38.0%
2020	56.0%	47.0%	43.0%
2021	61.0%	49.0%	41.0%
2022	68.0%	55.0%	45.0%
2023	77.0%	62.0%	53.0%
2024	87.0%	71.0%	64.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Sri Lanka

1,787 rows

Source	Type	Rows	Indicators	Years	Read from	Retrieved
UNAIDS AIDSinfo	Modelled estimate	617	26	2000–2024	aidsinfo.unaids.org	2026-10-20
UNICEF HIV/AIDS dataset	Modelled estimate	432	3	2010–2025	sdmx.data.unicef.org	2026-10-20
WHO Global Health Observatory	Modelled estimate	191	10	2000–2025	ghoapi.azureedge.net	2026-10-12
WHO Global Tuberculosis Programme	Programme record	155	16	2000–2025	extranet.who.int	2026-10-16
Global Fund Data Service	Programme record	93	7	2017–2025	fetch.theglobalfund.org	2026-10-12
WHO Global Health Expenditure Database	Expenditure account	63	7	2014–2022	apps.who.int	2026-10-12
IATI, through d-portal	Expenditure account	59	3	2000–2026	d-portal.org	2026-10-12
World Bank Open Data	Modelled estimate	51	2	2000–2025	api.worldbank.org	2026-10-12
OECD Creditor Reporting System	Expenditure account	43	3	2002–2024	sdmx.oecd.org	2026-10-12
ForeignAssistance.gov	Expenditure account	20	3	2005–2020	foreignassistance.gov	2026-10-29
UNAIDS Global AIDS Monitoring expenditure database	Expenditure account	20	8	2019–2023	hivfinancial.unaids.org	2026-10-12
Sri Lanka National STD/AIDS Control Programme annual report 2025	Programme record	16	1	2010–2025	aidscontrol.gov.lk	2026-10-16
WHO HIV testing services dashboard	Programme record	15	5	2018–2024	eic-database-290813.ew.r.appspot.com	2026-10-14
UNAIDS Data 2025 country databook	Expenditure account	8	2	2019–2023	aidsinfo.unaids.org	2026-10-15
Global Fund allocations	Expenditure account	4	1	2017–2026	fetch.theglobalfund.org	2026-10-12

Indicators held

70 of 150

Indicator	Domain	Unit	Rows	Years	Sources	Most recent value
Actual expenditure on collaborative TB/HIV activities	Financing	USD	7	2017–2023	WHO Global Tuberculosis Programme	$378 (2023)
Budget required for collaborative TB/HIV activities	Financing	USD	6	2018–2025	WHO Global Tuberculosis Programme	$562 (2025)
Country-reported HIV expenditure, all sources	Financing	USD	9	2013–2023	UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database	$7.4m (2023)
Domestic funding received by the national TB programme	Financing	USD	8	2017–2024	WHO Global Tuberculosis Programme	$1.4m (2024)
Domestic public HIV expenditure	Financing	USD	8	2019–2023	UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database	$3.0m (2023)
Expected Global Fund funding for the national TB programme	Financing	USD	8	2018–2025	WHO Global Tuberculosis Programme	$390k (2025)
Expected USAID funding for the national TB programme	Financing	USD	4	2018–2025	WHO Global Tuberculosis Programme	$0 (2025)
Expected domestic funding for the national TB programme	Financing	USD	8	2018–2025	WHO Global Tuberculosis Programme	$2.7m (2025)
Expected funding for collaborative TB/HIV activities	Financing	USD	6	2018–2025	WHO Global Tuberculosis Programme	$562 (2025)
External HIV and STD spending, national health accounts	Financing	USD	9	2014–2022	WHO Global Health Expenditure Database	$102.7m (2022)
External HIV financing (all donors, ODA)	Financing	USD	23	2002–2024	OECD Creditor Reporting System	$1.6m (2024)
External HIV financing from governments other than the United States (IATI)	Financing	USD	26	2000–2025	IATI, through d-portal	$20k (2025)
External HIV financing from multilateral bodies other than the Global Fund (IATI)	Financing	USD	15	2012–2026	IATI, through d-portal	$29k (2026)
External HIV financing from the United States (ODA)	Financing	USD	14	2005–2020	ForeignAssistance.gov, OECD Creditor Reporting System	$11k (2020)
Funding received for collaborative TB/HIV activities	Financing	USD	7	2017–2023	WHO Global Tuberculosis Programme	$378 (2023)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure	Financing	USD per three-year allocation cycle	4	2017–2026	Global Fund allocations	3,915,066 (2026)
Global Fund HIV disbursements to the country	Financing	USD	36	2007–2026	IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database	$852k (2026)
Global Fund funding received by the national TB programme	Financing	USD	8	2017–2024	WHO Global Tuberculosis Programme	$1.7m (2024)
Government HIV and STD spending as a share of government health spending	Financing	percent	9	2014–2022	WHO Global Health Expenditure Database	0.0% (2022)
Government HIV and STD spending, national health accounts	Financing	USD	9	2014–2022	WHO Global Health Expenditure Database	$193k (2022)
HIV and STD spending as a share of all external health spending	Financing	percent	9	2014–2022	WHO Global Health Expenditure Database	30.6% (2022)
HIV and STD spending as a share of all health spending	Financing	percent	9	2014–2022	WHO Global Health Expenditure Database	3.5% (2022)
HIV and STD spending, national health accounts	Financing	USD	9	2014–2022	WHO Global Health Expenditure Database	$103.2m (2022)
HIV spending on governance and sustainability	Financing	USD	1	2019	UNAIDS Global AIDS Monitoring expenditure database	$84k (2019)
HIV spending on prevention of vertical transmission	Financing	USD	1	2019	UNAIDS Global AIDS Monitoring expenditure database	$741k (2019)
HIV spending on treatment, care and support	Financing	USD	2	2019–2020	UNAIDS Global AIDS Monitoring expenditure database	$11.1m (2020)
International HIV expenditure (country-reported)	Financing	USD	8	2019–2023	UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database	$4.4m (2023)
PEPFAR expenditure, all US agencies	Financing	USD	1	2019	UNAIDS Global AIDS Monitoring expenditure database	$1.6m (2019)
Private HIV and STD spending, national health accounts	Financing	USD	9	2014–2022	WHO Global Health Expenditure Database	$330k (2022)
US HIV disbursements managed by USAID	Financing	USD	5	2007–2015	ForeignAssistance.gov	$7k (2015)
US HIV disbursements managed by other US agencies	Financing	USD	6	2005–2020	ForeignAssistance.gov	$11k (2020)
USAID funding received by the national TB programme	Financing	USD	1	2017	WHO Global Tuberculosis Programme	$0 (2017)
% of ALL PLHIV who are virally suppressed	Treatment cascade	percent	19	2016–2025	UNAIDS AIDSinfo, WHO Global Health Observatory	46.0% (2025)
% of PLHIV on ART (second 95, PLHIV base)	Treatment cascade	percent	41	2000–2025	UNAIDS AIDSinfo, WHO Global Health Observatory	52.0% (2025)
% of PLHIV who have been diagnosed (first 95)	Treatment cascade	percent	21	2017–2025	UNAIDS AIDSinfo, WHO Global Health Observatory	66.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART	Treatment cascade	percent	22	2003–2024	UNAIDS AIDSinfo	64.5% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy	Treatment cascade	percent	1	2018	UNAIDS AIDSinfo	20.7% (2018)
% of people newly enrolled in HIV treatment diagnosed with TB disease	Treatment cascade	percent	11	2013–2024	UNAIDS AIDSinfo	7.4% (2024)
% of people newly enrolled in HIV treatment started on TB preventive therapy	Treatment cascade	percent	8	2013–2022	UNAIDS AIDSinfo	17.4% (2022)
% of people on ART who are virally suppressed (third 95)	Treatment cascade	percent	10	2016–2025	WHO Global Health Observatory	89.0% (2025)
% of returned HIV test results that were positive	Treatment cascade	percent	9	2022–2024	UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard	0.1% (2024)
HIV self-test kits distributed	Treatment cascade	count	3	2022–2024	WHO HIV testing services dashboard	5,164 (2024)
HIV tests performed at a health facility	Treatment cascade	count	3	2018–2024	WHO HIV testing services dashboard	1,176,946 (2024)
HIV tests performed through community outreach	Treatment cascade	count	2	2018–2024	WHO HIV testing services dashboard	40,654 (2024)
HIV tests performed with the result returned to the person	Treatment cascade	count	15	2017–2024	Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard	1,217,600 (2024)
HIV-exposed infants tested within two months of birth	Treatment cascade	percent	14	2010–2024	UNAIDS AIDSinfo	63.0% (2024)
HIV-positive TB patients started or continued on ART	Treatment cascade	count	16	2015–2025	Global Fund Data Service, WHO Global Tuberculosis Programme	46 (2025)
Key-population people tested for HIV (count over the period)	Treatment cascade	count	34	2017–2025	Global Fund Data Service	By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200	Treatment cascade	percent	6	2015–2020	UNAIDS AIDSinfo	30.0% (2020)
Notified HIV cases, national case surveillance	Treatment cascade	count	16	2010–2025	Sri Lanka National STD/AIDS Control Programme annual report 2025	874 (2025)
Number of people on ART (PEPFAR MER TX_CURR)	Treatment cascade	count	76	2000–2025	Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory	4,535 (2025)
People living with HIV on ART who started TB preventive therapy	Treatment cascade	count	4	2022–2025	Global Fund Data Service	108 (2025)
People newly enrolled on ART during the year	Treatment cascade	count	12	2013–2024	WHO Global Tuberculosis Programme	758 (2024)
Pregnant women tested for HIV in antenatal care	Treatment cascade	percent	10	2015–2024	UNAIDS AIDSinfo	98.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT	Treatment cascade	count	15	2010–2024	UNAIDS AIDSinfo	23 (2024)
TB patients recorded as HIV-positive	Treatment cascade	count	10	2015–2024	WHO Global Tuberculosis Programme	68 (2024)
TB patients with an HIV test result recorded	Treatment cascade	count	10	2015–2024	WHO Global Tuberculosis Programme	8,787 (2024)
AIDS-related deaths	Epidemic estimates	count	295	2000–2025	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory	200 (2025)
Deaths from TB among people living with HIV	Epidemic estimates	count	50	2000–2024	UNAIDS AIDSinfo, WHO Global Tuberculosis Programme	35 (2024)
HIV prevalence among a key population	Epidemic estimates	percent	4	2024	UNAIDS AIDSinfo	By population group, sex or age only, to 2024
HIV prevalence, ages 15-49	Epidemic estimates	percent	50	2000–2024	UNAIDS AIDSinfo, World Bank Open Data	0.1% (2024)
Incident TB cases among people living with HIV	Epidemic estimates	count	50	2000–2024	UNAIDS AIDSinfo, WHO Global Tuberculosis Programme	110 (2024)
New HIV infections	Epidemic estimates	count	295	2000–2025	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory	860 (2025)
People living with HIV	Epidemic estimates	count	295	2000–2025	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory	8,700 (2025)
Key-population members reached by prevention programmes	Prevention and outreach	percent	4	2024	UNAIDS AIDSinfo	By population group, sex or age only, to 2024
Key-population people reached by outreach (count over the period)	Prevention and outreach	count	34	2017–2025	Global Fund Data Service	By population group, sex or age only, to 2025
Male condoms distributed in a year	Prevention and outreach	count	4	2019–2023	UNAIDS AIDSinfo	1,210,411 (2023)
People receiving PrEP	Prevention and outreach	count	2	2020–2025	Global Fund Data Service, UNAIDS AIDSinfo	100 (2020)
Estimated size of a key population	Population denominators	count	5	2024	UNAIDS AIDSinfo	By population group, sex or age only, to 2024
Total population	Population denominators	count	26	2000–2025	World Bank Open Data	21,756,000 (2025)

Every row shown on the Sri Lanka page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.